Trial Search Results
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
The purpose of this study is to determine whether [18F]FHBG is suitable for use as an imaging probe in cancer or rheumatoid arthritis patients enrolled in cell or gene therapy trials. In this phase 1 study we will assess the safety and biodistribution of [18F]FHBG in patients.
Stanford is currently not accepting patients for this trial.
Sanjiv Sam Gambhir
- Radiation: [18F]FHBG
- Clinical diagnosis of brain tumor or rheumatoid arthritis
- Below 18 years of age
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study